Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recall Survival: Fast, Detailed Communication Can Save A Brand

This article was originally published in The Tan Sheet

Executive Summary

Manufacturers should be prepared before a recall, with designated spokespeople and a dedicated website that can launch quickly, experts advised during a CHPA webinar. Firms should make clear, first and foremost, that they care about their consumers’ safety.

You may also be interested in...



FDA’s Office Of Regulatory Affairs Scrutinizes Recalls Process

ORA sets a 2012 priority of improving the efficiency of the recall process to help reach its overall enforcement and compliance goal of preventing public health emergencies.

H&P/Triad OTC Manufacturing Woes Lead To $6M FDA Seizure

At FDA's request, the U.S. Marshals Service seized OTC drug products from sister companies that had multiple run-ins with the agency since 2009 – Triad Group and H&P Industries.

J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores

J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105801

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel